Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including JPMorgan Chase, Nurix Therapeutics, V.F. Corporation, Affirm Holdings, Snap Inc., Wells Fargo, Benitec Biopharma, Boot Barn Holdings, Fastenal Company, and ArcBest Corporation. These changes reflect varying outlooks on the companies' future performance.
October 14, 2024 | 2:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities raised Benitec Biopharma's price target from $16 to $18, maintaining a Market Outperform rating. Shares closed at $10.86.
The increased price target and Market Outperform rating suggest positive sentiment, likely leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Piper Sandler raised Boot Barn Holdings' price target from $147 to $179, maintaining an Overweight rating. Shares closed at $159.36.
The increased price target and Overweight rating indicate positive expectations, likely boosting the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Evercore ISI Group raised JPMorgan Chase's price target from $217 to $230, maintaining an Outperform rating. Shares closed at $222.29.
The increase in price target and maintained Outperform rating suggest positive sentiment, likely boosting short-term stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Stifel raised V.F. Corporation's price target from $21 to $25, maintaining a Buy rating. Shares closed at $20.33.
The increase in price target and Buy rating indicate positive expectations, likely leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Evercore ISI Group raised Wells Fargo's price target from $68 to $71, maintaining an Outperform rating. Shares closed at $60.99.
The increased price target and Outperform rating indicate positive expectations, likely boosting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
NEUTRAL IMPACT
Wedbush raised Affirm Holdings' price target from $25 to $45, upgrading the stock from Underperform to Neutral. Shares closed at $47.08.
The upgrade to Neutral and increased price target suggest a more balanced view, with limited short-term impact as the current price is above the target.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Baird raised Fastenal Company's price target from $67 to $80, maintaining a Neutral rating. Shares closed at $76.82.
The increased price target with a Neutral rating suggests a balanced view, with limited short-term impact as the current price is near the target.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
RBC Capital cut Nurix Therapeutics' price target from $27 to $26, maintaining an Outperform rating. Shares closed at $23.63.
The slight decrease in price target with an Outperform rating suggests a neutral short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
TD Cowen cut ArcBest Corporation's price target from $131 to $114, downgrading the stock from Buy to Hold. Shares closed at $105.95.
The downgrade to Hold and reduced price target suggest negative sentiment, likely leading to a short-term price decrease.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Stifel cut Snap Inc.'s price target from $13 to $11, maintaining a Hold rating. Shares closed at $11.13.
The reduced price target and Hold rating suggest negative sentiment, likely leading to a short-term price decrease.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75